Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiko Iida

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 4, 2003
[Biomedical imaging in pharmacology with nuclear medical imaging methodologies: positron emission tomography (PET) and single photon emission computed tomography (SPECT)]Hideo Saji, Yasuhiko Iida
Neurotoxicity Research|January 11, 2005
Binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a metabolite of haloperidol, to synthetic melanin: implications for the dopaminergic neurotoxicity of HPP+Hidekazu Kawashima, Yasuhiko Iida, Youji Kitamura, et al.
Annals of Nuclear Medicine|September 17, 2005
Current status of cancer therapy with radiolabeled monoclonal antibodyNoboru Oriuchi, Tetsuya Higuchi, Hirofumi Hanaoka, et al.
Japanese Journal of Pharmacology|September 18, 2002
Brain extraction of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a neurotoxic metabolite of haloperidol: studies using [3H]HPP+Hidekazu Kawashima, Yasuhiko Iida, Youji Kitamura, et al.
Nuclear Medicine and Biology|March 12, 2004
Evaluation of radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine as a ligand for brain norepinephrine transporter imagingYasushi Kiyono, Naoki Kanegawa, Hidekazu Kawashima, et al.
Cancer Research|May 13, 2010
Phosphorescent light-emitting iridium complexes serve as a hypoxia-sensing probe for tumor imaging in living animalsShaojuan Zhang, Masahiro Hosaka, Toshitada Yoshihara, et al.
Synapse (New York, N.Y.)|May 28, 2010
In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effectsMasashi Ueda, Yasuhiko Iida, Tomoki Yoneyama, et al.
Nuclear Medicine and Biology|September 23, 2003
A new norepinephrine transporter imaging agent for cardiac sympathetic nervous function imaging: radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamineYasushi Kiyono, Naoki Kanegawa, Hidekazu Kawashima, et al.
Brain Research|February 14, 2008
5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neuronsMasashi Ueda, Yasuhiko Iida, Youji Kitamura, et al.
Anesthesia and Analgesia|August 26, 2006
Changes in electroencephalographic bicoherence during sevoflurane anesthesia combined with intravenous fentanylYasuhiro Morimoto, Satoshi Hagihira, Satoshi Yamashita, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 4, 2003
[Biomedical imaging in pharmacology with nuclear medical imaging methodologies: positron emission tomography (PET) and single photon emission computed tomography (SPECT)]Hideo Saji, Yasuhiko Iida
Neurotoxicity Research|January 11, 2005
Binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a metabolite of haloperidol, to synthetic melanin: implications for the dopaminergic neurotoxicity of HPP+Hidekazu Kawashima, Yasuhiko Iida, Youji Kitamura, et al.
Annals of Nuclear Medicine|September 17, 2005
Current status of cancer therapy with radiolabeled monoclonal antibodyNoboru Oriuchi, Tetsuya Higuchi, Hirofumi Hanaoka, et al.
Japanese Journal of Pharmacology|September 18, 2002
Brain extraction of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a neurotoxic metabolite of haloperidol: studies using [3H]HPP+Hidekazu Kawashima, Yasuhiko Iida, Youji Kitamura, et al.
Nuclear Medicine and Biology|March 12, 2004
Evaluation of radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine as a ligand for brain norepinephrine transporter imagingYasushi Kiyono, Naoki Kanegawa, Hidekazu Kawashima, et al.
Cancer Research|May 13, 2010
Phosphorescent light-emitting iridium complexes serve as a hypoxia-sensing probe for tumor imaging in living animalsShaojuan Zhang, Masahiro Hosaka, Toshitada Yoshihara, et al.
Synapse (New York, N.Y.)|May 28, 2010
In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effectsMasashi Ueda, Yasuhiko Iida, Tomoki Yoneyama, et al.
Nuclear Medicine and Biology|September 23, 2003
A new norepinephrine transporter imaging agent for cardiac sympathetic nervous function imaging: radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamineYasushi Kiyono, Naoki Kanegawa, Hidekazu Kawashima, et al.
Brain Research|February 14, 2008
5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neuronsMasashi Ueda, Yasuhiko Iida, Youji Kitamura, et al.
Anesthesia and Analgesia|August 26, 2006
Changes in electroencephalographic bicoherence during sevoflurane anesthesia combined with intravenous fentanylYasuhiro Morimoto, Satoshi Hagihira, Satoshi Yamashita, et al.
Pageof 5